Discriminative Capacity of CT Volumetry to Identify Autonomous Cortisol Secretion in Incidental Adrenal Adenomas.


Journal

The Journal of clinical endocrinology and metabolism
ISSN: 1945-7197
Titre abrégé: J Clin Endocrinol Metab
Pays: United States
ID NLM: 0375362

Informations de publication

Date de publication:
19 04 2022
Historique:
received: 08 09 2021
pubmed: 13 1 2022
medline: 21 4 2022
entrez: 12 1 2022
Statut: ppublish

Résumé

Incidentally discovered adrenal adenomas are common. Assessment for possible autonomous cortisol excess (ACS) is warranted for all adrenal adenomas, given the association with increased cardiometabolic disease. To evaluate the discriminatory capacity of 3-dimensional volumetry on computed tomography (CT) to identify ACS. Two radiologists, blinded to hormonal levels, prospectively analyzed CT images of 149 adult patients with unilateral, incidentally discovered, adrenal adenomas. Diameter and volumetry of the adenoma, volumetry of the contralateral adrenal gland, and the adenoma volume-to-contralateral gland volume (AV/CV) ratio were measured. ACS was defined as cortisol ≥ 1.8 mcg/dL after 1-mg dexamethasone suppression test (DST) and a morning ACTH ≤ 15. pg/mL. We observed that ACS was diagnosed in 35 (23.4%) patients. Cortisol post-DST was positively correlated with adenoma diameter and volume, and inversely correlated with contralateral adrenal gland volume. Cortisol post-DST was positively correlated with the AV/CV ratio (r = 0.46, P < 0.001) and ACTH was inversely correlated (r = -0.28, P < 0.001). The AV/CV ratio displayed the highest odds ratio (1.40; 95% CI, 1.18-1.65) and area under curve (0.91; 95% CI, 0.86-0.96) for predicting ACS. An AV/CV ratio ≥ 1 (48% of the cohort) had a sensitivity of 97% and a specificity of 70% to identify ACS. CT volumetry of adrenal adenomas and contralateral adrenal glands has a high discriminatory capacity to identify ACS. The combination of this simple and low-cost radiological phenotyping can supplement biochemical testing to substantially improve the identification of ACS.

Identifiants

pubmed: 35020922
pii: 6502454
doi: 10.1210/clinem/dgac005
pmc: PMC9272424
doi:

Substances chimiques

Adrenocorticotropic Hormone 9002-60-2
Hydrocortisone WI4X0X7BPJ

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e1946-e1953

Subventions

Organisme : Fondecyt
ID : #1190419
Organisme : NIDDK NIH HHS
ID : R01 DK115392
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL153004
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK061618
Pays : United States

Commentaires et corrections

Type : ErratumIn

Informations de copyright

© The Author(s) 2022. Published by Oxford University Press on behalf of the Endocrine Society. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Références

Circulation. 2019 Jun 18;139(25):e1082-e1143
pubmed: 30586774
AJR Am J Roentgenol. 2017 Jul;209(1):122-129
pubmed: 28402131
Endocrinol Metab Clin North Am. 2018 Jun;47(2):375-383
pubmed: 29754638
Clin Endocrinol (Oxf). 2017 Mar;86(3):325-331
pubmed: 27748964
J Endocr Soc. 2018 Mar 16;2(4):374-385
pubmed: 29644340
Clin Pharmacol Ther. 2019 Dec;106(6):1209-1221
pubmed: 31206616
Nat Rev Endocrinol. 2011 Jun 28;7(11):668-80
pubmed: 21709710
Visc Med. 2020 Feb;36(1):15-19
pubmed: 32110652
Int J Urol. 2018 Jun;25(6):583-588
pubmed: 29651813
Best Pract Res Clin Endocrinol Metab. 2021 Jan;35(1):101491
pubmed: 33593680
Eur J Endocrinol. 2018 May;178(5):439-446
pubmed: 29467231
Diabetes Res Clin Pract. 2021 Jul 31;:108972
pubmed: 34343595
J Comput Assist Tomogr. 2015 Sep-Oct;39(5):741-6
pubmed: 26035405
World J Surg. 2020 Nov;44(11):3778-3785
pubmed: 32651604
Endocrine. 2018 Mar;59(3):529-537
pubmed: 29332161
Best Pract Res Clin Endocrinol Metab. 2020 May;34(3):101427
pubmed: 32448594
BMC Surg. 2016 Jun 08;16(1):41
pubmed: 27278528
Ann Endocrinol (Paris). 2009 Sep;70(4):211-7
pubmed: 19457469
J Clin Endocrinol Metab. 2014 Dec;99(12):4462-70
pubmed: 25238207
Ann Intern Med. 2016 Oct 18;165(8):533-542
pubmed: 27479926
Eur J Endocrinol. 2016 Aug;175(2):R51-64
pubmed: 27257145
N Engl J Med. 2007 Feb 8;356(6):601-10
pubmed: 17287480
J Clin Endocrinol Metab. 2019 Feb 1;104(2):312-318
pubmed: 30383267
J Clin Endocrinol Metab. 2000 Feb;85(2):637-44
pubmed: 10690869
Eur J Endocrinol. 2016 Aug;175(2):G1-G34
pubmed: 27390021
Eur J Endocrinol. 2012 Apr;166(4):669-77
pubmed: 22267278
Endocr Rev. 2020 Dec 1;41(6):
pubmed: 32266384
Eur J Endocrinol. 2017 Dec;177(6):475-483
pubmed: 28870984
Eur Radiol. 2016 Aug;26(8):2494-501
pubmed: 26515550
J Clin Endocrinol Metab. 2021 Oct 21;106(11):3331-3353
pubmed: 34260734
Eur J Endocrinol. 2020 Sep;183(3):325-333
pubmed: 32717717
Radiographics. 2020 Jul-Aug;40(4):1041-1060
pubmed: 32609593
AJR Am J Roentgenol. 2017 Jun;208(6):1206-1217
pubmed: 28225653
Surgery. 2007 Dec;142(6):900-5; discussion 905.e1
pubmed: 18063074
Psychiatry Res. 1987 Jul;21(3):189-97
pubmed: 3628606
J Am Coll Cardiol. 2019 Sep 10;74(10):e177-e232
pubmed: 30894318
Eur J Endocrinol. 2016 Dec;175(6):R283-R295
pubmed: 27450696
J Comput Assist Tomogr. 2013 Jul-Aug;37(4):528-42
pubmed: 23863528

Auteurs

Roberto Olmos (R)

Department of Endocrinology, Pontificia Universidad Catolica de Chile, Santiago, 8330077, Chile.
Program for Adrenal Disorders, CETREN UC, Pontificia Universidad Catolica de Chile, Santiago, 8330077, Chile.

Nicolás Mertens (N)

Department of Radiology, Pontificia Universidad Catolica de Chile, Santiago, 8330077, Chile.

Anand Vaidya (A)

Center for Adrenal Disorders, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.

Thomas Uslar (T)

Department of Endocrinology, Pontificia Universidad Catolica de Chile, Santiago, 8330077, Chile.
Program for Adrenal Disorders, CETREN UC, Pontificia Universidad Catolica de Chile, Santiago, 8330077, Chile.

Paula Fernandez (P)

Program for Adrenal Disorders, CETREN UC, Pontificia Universidad Catolica de Chile, Santiago, 8330077, Chile.

Francisco J Guarda (FJ)

Department of Endocrinology, Pontificia Universidad Catolica de Chile, Santiago, 8330077, Chile.

Álvaro Zúñiga (Á)

Department of Urology, Pontificia Universidad Catolica de Chile, Santiago 8330077, Chile.

Ignacio San Francisco (I)

Department of Urology, Pontificia Universidad Catolica de Chile, Santiago 8330077, Chile.

Alvaro Huete (A)

Department of Radiology, Pontificia Universidad Catolica de Chile, Santiago, 8330077, Chile.

René Baudrand (R)

Department of Endocrinology, Pontificia Universidad Catolica de Chile, Santiago, 8330077, Chile.
Program for Adrenal Disorders, CETREN UC, Pontificia Universidad Catolica de Chile, Santiago, 8330077, Chile.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH